News
Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. | Novartis has terminated a phase 2 trial evaluating an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback